[{"address1": "5750 Explorer Drive", "address2": "Suite 404", "city": "Mississauga", "state": "ON", "zip": "L4W 0A9", "country": "Canada", "phone": "905 602 5840", "website": "https://www.cipherpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig J. Mull", "title": "Interim CEO & Chairman of the Board", "fiscalYear": 2023, "totalPay": 79324, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bryan  Jacobs", "title": "President", "fiscalYear": 2023, "totalPay": 300177, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Mailling", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Emilio  Presti", "title": "Director of Sales & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hamed  Ghanei", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shengnan  Guo", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.4, "open": 8.4, "dayLow": 8.28, "dayHigh": 8.42, "regularMarketPreviousClose": 8.4, "regularMarketOpen": 8.4, "regularMarketDayLow": 8.28, "regularMarketDayHigh": 8.42, "payoutRatio": 0.0, "beta": 1.176, "trailingPE": 13.222222, "forwardPE": 16.66, "volume": 12679, "regularMarketVolume": 12679, "averageVolume": 17947, "averageVolume10days": 16520, "averageDailyVolume10Day": 16520, "bid": 8.32, "ask": 8.36, "bidSize": 400, "askSize": 400, "marketCap": 214797376, "fiftyTwoWeekLow": 4.96, "fiftyTwoWeekHigh": 14.6, "priceToSalesTrailing12Months": 8.117508, "fiftyDayAverage": 9.565, "twoHundredDayAverage": 9.4628, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 244298560, "profitMargins": 0.59922004, "floatShares": 14833181, "sharesOutstanding": 25589500, "sharesShort": 11427, "sharesShortPriorMonth": 48425, "sharesShortPreviousMonthDate": 1477872000, "dateShortInterest": 1480464000, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.42001, "heldPercentInstitutions": 0.0152900005, "shortRatio": 0.97, "impliedSharesOutstanding": 25786000, "bookValue": 3.863, "priceToBook": 2.1563551, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "earningsQuarterlyGrowth": -0.96, "netIncomeToCommon": 15856000, "trailingEps": 0.63, "forwardEps": 0.5, "enterpriseToRevenue": 9.232, "enterpriseToEbitda": 19.43, "52WeekChange": 0.59546316, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 8.33, "recommendationKey": "none", "totalCash": 9524000, "totalCashPerShare": 0.372, "ebitda": 12573000, "totalDebt": 40752000, "quickRatio": 1.567, "currentRatio": 2.003, "totalRevenue": 26461000, "debtToEquity": 41.223, "revenuePerShare": 1.085, "returnOnAssets": 0.05055, "returnOnEquity": 0.17977, "grossProfits": 21375000, "freeCashflow": -78524128, "operatingCashflow": 13078000, "earningsGrowth": -0.963, "revenueGrowth": 0.709, "grossMargins": 0.80779, "ebitdaMargins": 0.47515, "operatingMargins": 0.18033001, "financialCurrency": "USD", "symbol": "CPHRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Cipher Pharmaceuticals, Inc.", "longName": "Cipher Pharmaceuticals Inc.", "marketState": "CLOSED", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1138890600000, "regularMarketChange": -0.069999695, "regularMarketDayRange": "8.28 - 8.42", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 17947, "fiftyTwoWeekLowChange": 3.37, "fiftyTwoWeekLowChangePercent": 0.67943543, "fiftyTwoWeekRange": "4.96 - 14.6", "fiftyTwoWeekHighChange": -6.2700005, "fiftyTwoWeekHighChangePercent": -0.42945206, "fiftyTwoWeekChangePercent": 59.546314, "earningsTimestampStart": 1731020402, "earningsTimestampEnd": 1731020402, "earningsCallTimestampStart": 1731072600, "earningsCallTimestampEnd": 1731072600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.63, "epsForward": 0.5, "regularMarketChangePercent": -0.83332974, "regularMarketPrice": 8.33, "corporateActions": [], "regularMarketTime": 1740775381, "exchange": "OQX", "messageBoardId": "finmb_8201659", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -1.2349997, "fiftyDayAverageChangePercent": -0.12911654, "twoHundredDayAverageChange": -1.1328001, "twoHundredDayAverageChangePercent": -0.11971088, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Cipher Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]